Search Results - "Snegireva, L."

Refine Results
  1. 1
  2. 2
  3. 3

    Invasive fungal infections in children with rheumatic diseases by Kozlova, O. P., Kostik, M. M., Kuznetsova, M. D., Dubko, M. F., Snegireva, L. S., Shavkin, A. L., Ligostaeva, E. A., Kopchak, O. L., Ignatieva, S. M., Bogomolova, T. S., Klimko, N. N.

    Published in Zhurnal infektologii (21-01-2021)
    “…Introduction . In children with rheumatic diseases, severe fungal infections (invasive mycoses – IM) are not well understood. Objectives . To analyze risk…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Primary idiopathic hypertrophic osteoarthropathy in a child: characteristics of the disease with a case report by Lyubimova, N. A., Snegireva, L. S., Terentyev, N. A., Idrisova, R. V., Avramenko, V. V., Imelbaev, A. I., Krasnogorskaya, O. L., Kostik, M. M.

    Published in Sovremennai͡a︡ revmatologii͡a (01-01-2018)
    “…The paper gives the data available in the literature on the relatively rare disease hypertrophic osteoarthropathy (HOA). This syndrome includes symptoms, such…”
    Get full text
    Journal Article
  6. 6

    Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up by Kostik, M. M., Isupova, E. A., Chikova, I. A., Dubko, M. F., Masalova, V. V., Snegireva, L. S., Kalashnikova, O. V., Chasnyk, V. G.

    Published in Sovremennai͡a︡ revmatologii͡a (01-01-2018)
    “…Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Current approaches to diagnosing and treating macrophage activation syndrome in children with rheumatic diseases by Kostik, M. M., Dubko, M. F., Masalova, V. V., Snegireva, L. S., Chikova, I. A., Isupova, E. A., Kalashnikova, O. V., Chasnyk, V. G.

    Published in Sovremennai͡a︡ revmatologii͡a (23-03-2015)
    “…Macrophage activation syndrome (MAS) is a severe life-threatening complication presenting with hemophagocytosis, pancytopenia, coagulopathy, and liver and CNS…”
    Get full text
    Journal Article
  12. 12

    Production of sticks of VT1-0-type alloys by a resource-saving ingot-free technology by Pol’kin, I. S., Golubev, S. M., Snegireva, L. A., Zenin, V. A., Pavlov, V. M.

    Published in Materials science (New York, N.Y.) (01-05-2008)
    “…We studied the possibilities of a resource-saving ingot-free technology for the production of sticks of VT1-0 alloy by the method of direct phased deformation…”
    Get full text
    Journal Article
  13. 13

    How to identify a patient with autoinflammatory syndrome: Clinical and diagnostic algorithms by Kostik, Mikhail Mikhailovich, Snegireva, L S, Dubko, M F, Masalova, V V, Likhacheva, T S, Kalashnikova, O V, Chasnyk, V G

    Published in Sovremennai͡a︡ revmatologii͡a (14-10-2013)
    “…Autoinflammatory syndromes (AISs) are a group of predominantly hereditary diseases associated with the spontaneous uncontrolled production of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study by Chasnyk, Vyacheslav, Palmblad, Karin, I. Brunner, Hermine, Marzan, Katherine, Schneider, Rayfel, Horneff, Gerd, Martini, Alberto, Anton, Jordi, Wei, Xiaoling, Ruperto, Nicolino, Abrams, Ken, Ulbrich, A., Fodor, S., Lauwerys, B., Brichard, B., Knupp Feitosa, S., Felix Rodrigues, M., Mattei de, L., Kozu, K., Laxer, Ronald, Houghton, K., Mogenet, A., Bader Meunier, B., Meyzer, C., Semeraro, M., Ben‐Brahim, O., Kone‐Paut, I., Galeotti, C., Dusser, P., Duquesne, A., Desjonqueres, M., Foeldvari, I., Kienast, A., Geikowski, T., Schulz, A., Hirdes, M., Janda, A., Jacob, A., Emerich, C., Raab, A., Minden, K., Lieber, M., Haselbusch, D., Kolbeck, H., Kuemmerle Deschner, J., Hansmann, S., Schleich, T., Magunia, I., Anders, N., Helling‐Bakki, A., Garan, D., Orban, I., Butbul, Y., Helo, M., Uziel, Y., Haviv, R., Moshe, V., Rothschild, M., Harel, L., Amarilyo, G., Said, M., Gerstein, M., Ravelli, A., Schiappapietra, B., Varnier, G., Finetti, M., Caorsi, R., Pontikaki, I., Gerloni, V., Ubiali, T., Vastert, S., Szczygielska, I., Kwiatkowska, M., Snegireva, L., Kostik, M., Kalashnikova, O., Galindo Zavala, R., Iglesias, E., Calzada, J., Gamir, M. L., Merino, R., Alcobendas, R., Remesal, A., Calvo, I., Gonzalez, I., Barut, K., Adrovic, A., Sahin, S., Gozdenur Savci, R., Demir, S., Bilginer, Y., Batu, E. D., Reiff, Andreas, Brown, Diana, Shaham, Bracha, Higgins, G., Spencer, C., Jones, K., Farley, S., Akoghlanian, S.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-02-2021)
    “…Objective To evaluate the efficacy and safety of 2 canakinumab monotherapy tapering regimens in order to maintain complete clinical remission in children with…”
    Get full text
    Journal Article
  16. 16

    Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment by Kostik, Mikhail M, Isupova, Eugenia A, Chikova, Irina A, Dubko, Margarita F, Masalova, Vera V, Snegireva, Ludmila S, Kalashnikova, Olga V, Chasnyk, Vyacheslav G

    Published in Clinical and experimental rheumatology (01-03-2018)
    “…The aim of our study was to evaluate disease courses and outcomes of sJIA children undergoing tocilizumab (TCZ) treatment, and to establish the predictors…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    DIFFERENTIATED APPROACH TO NON-BACTERIAL OSTEOMYELITIS TREATMENT IN CHILDREN: THE RETROSPECTIVE STUDY RESULTS by Kostik, M. M., Kopchak, O. L., Chikova, I. A., Isupova, E. A., Masalova, V. V., Dubko, M. F., Snegireva, L. S., Kalashnikova, O. V., Mushkin, А. Y., Chasnyk, V. G.

    Published in Voprosy sovremennoĭ pediatrii (01-11-2016)
    “…Differentiated Approach to Non-Bacterial Osteomyelitis Treatment in Children: the Retrospective Study Results Background. Low efficacy of the therapy of…”
    Get full text
    Journal Article